ARA-290 vs BPC-157
Tissue-protective EPO fragment vs soft-tissue repair peptide.
| Attribute | ARA-290 Cibinetide | BPC-157 Body Protection Compound 157 |
|---|---|---|
| Category | Immune System & Inflammation | Healing & Recovery |
| Best known for | Neuropathy and tissue repair research | Tendon, ligament, and gut healing research |
| In plain English | ARA-290 isolates the tissue-healing effects of EPO without the red-blood-cell-boosting effects. | Think of BPC-157 as the peptide that researchers reach for when they want to study how soft tissue heals — tendons, ligaments, the gut lining, and connective tissue. It's been studied heavily in animal models for repair. |
| How it works | Selectively activates the innate repair receptor (IRR), promoting tissue protection and repair without erythropoiesis. | In animal studies it appears to promote new blood vessel formation (angiogenesis), increase growth factor receptor expression (especially VEGFR2), and modulate the nitric oxide system. The net effect in research models is faster tissue repair. |
| Researchers study | Diabetic neuropathy, sarcoidosis-related small-fiber neuropathy, and tissue repair. | Tendon-to-bone healing, ligament repair, gut barrier integrity, ulcer healing, muscle crush injury recovery, and brain–gut axis modulation. |
| Internet discussion | Niche discussion in chronic pain and neuropathy circles. | Online forums (Reddit's r/Peptides, AnabolicMinds, longevity Twitter) treat BPC-157 as the default 'recovery stack' addition. Stories range from rotator cuff and tendinopathy anecdotes to gut issues like IBS and leaky gut. |
ARA-290
Neuropathy and tissue repair research
ARA-290 isolates the tissue-healing effects of EPO without the red-blood-cell-boosting effects.
Selectively activates the innate repair receptor (IRR), promoting tissue protection and repair without erythropoiesis.
Diabetic neuropathy, sarcoidosis-related small-fiber neuropathy, and tissue repair.
Niche discussion in chronic pain and neuropathy circles.
ARA-290 is an EPO-derived peptide researched for tissue repair and neuropathy without RBC effects.
BPC-157
Tendon, ligament, and gut healing research
Think of BPC-157 as the peptide that researchers reach for when they want to study how soft tissue heals — tendons, ligaments, the gut lining, and connective tissue. It's been studied heavily in animal models for repair.
In animal studies it appears to promote new blood vessel formation (angiogenesis), increase growth factor receptor expression (especially VEGFR2), and modulate the nitric oxide system. The net effect in research models is faster tissue repair.
Tendon-to-bone healing, ligament repair, gut barrier integrity, ulcer healing, muscle crush injury recovery, and brain–gut axis modulation.
Online forums (Reddit's r/Peptides, AnabolicMinds, longevity Twitter) treat BPC-157 as the default 'recovery stack' addition. Stories range from rotator cuff and tendinopathy anecdotes to gut issues like IBS and leaky gut.
BPC-157 is the most-discussed research peptide for soft-tissue repair, with strong animal data on tendons, ligaments, and gut healing. Human clinical data is limited.